These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1653109)

  • 21. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of specific genetic alterations in cancer cells.
    Huebner K; Ohta M; Lubinski J; Berd D; Magüire HC
    Semin Oncol; 1996 Feb; 23(1):22-30. PubMed ID: 8607029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene.
    Veronese ML; Bullrich F; Negrini M; Croce CM
    Cancer Res; 1996 Feb; 56(4):728-32. PubMed ID: 8631004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation.
    Bocchetta M; Carbone M
    Oncogene; 2004 Aug; 23(38):6484-91. PubMed ID: 15322519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antioncogenes: models for tumors in children].
    Junien C; Henry I; Jeanpierre C; Lavedan C; Antignac C; Puech A; Beroud C
    Bull Cancer; 1991 Jan; 78(1):57-68. PubMed ID: 2021687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics: toward an understanding of childhood cancer.
    Kreissman SG
    Semin Pediatr Surg; 1993 Feb; 2(1):2-10. PubMed ID: 8062019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.
    Murakami Y
    Oncogene; 2002 Oct; 21(45):6936-48. PubMed ID: 12362275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular basis of tumor formation. Significance for the diagnosis of malignant diseases].
    Brach MA; Sott C; Belka C; Herrmann F
    Dtsch Med Wochenschr; 1995 Jan; 120(3):73-9. PubMed ID: 7828466
    [No Abstract]   [Full Text] [Related]  

  • 37. How cancer gene testing can benefit patients.
    Murphy P; Bray W
    Mol Med Today; 1997 Apr; 3(4):147-52. PubMed ID: 9134527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of mitotic recombination in carcinogenesis.
    Sengstag C
    Crit Rev Toxicol; 1994; 24(4):323-53. PubMed ID: 7857521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21.
    LaForgia S; Morse B; Levy J; Barnea G; Cannizzaro LA; Li F; Nowell PC; Boghosian-Sell L; Glick J; Weston A
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5036-40. PubMed ID: 1711217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy of cancer through restoration of tumor-suppressor functions?
    Friedmann T
    Cancer; 1992 Sep; 70(6 Suppl):1810-7. PubMed ID: 1516033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.